Prenetics Global - PRE Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $60.00
  • Forecasted Upside: 1,065.05%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$5.15
▲ +0.02 (0.39%)

This chart shows the closing price for PRE by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Prenetics Global Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PRE and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PRE

Analyst Price Target is $60.00
▲ +1,065.05% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Prenetics Global in the last 3 months. The average price target is $60.00, with a high forecast of $60.00 and a low forecast of $60.00. The average price target represents a 1,065.05% upside from the last price of $5.15.

This chart shows the closing price for PRE for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 contributing investment analysts is to buy stock in Prenetics Global. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/31/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/29/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/27/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/28/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/26/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/24/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/23/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/22/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/26/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$60.00Low
9/19/2023Cantor FitzgeraldLower TargetOverweight ➝ Overweight$90.00 ➝ $60.00Low
8/22/2023Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$90.00Low
1/18/2023Cantor FitzgeraldInitiated CoverageOverweight$105.00Low
7/12/2022CitigroupInitiated CoverageBuyLow
(Data available from 2/22/2019 forward)

News Sentiment Rating

0.52 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
7/27/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
8/26/2023
  • 1 very positive mentions
  • 1 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
9/25/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/25/2023
  • 1 very positive mentions
  • 6 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
11/24/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
12/24/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/23/2024
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/22/2024

Current Sentiment

  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Prenetics Global logo
Prenetics Global Limited operates as a diagnostics and genetic testing company in Hong Kong and the United Kingdom. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring device that offers COVID-19 testing solutions for professional use and home use. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; ACTOnco, a comprehensive test that helps clinicians choose the optimal treatment for all major solid tumors; ACTDrug+, a screening test that checks for 40 cancer genes to map drug options and provide treatment strategy options; ACTLung, a test focused on biomarkers associated with lung cancer for targeted therapy; ACTFusion, a test that decodes 13 fusion genes and more than 350 transcripts to map drug options; and ACTCerebra, a genomic profiling service for solid tumors. It also offers ACTMonitor, a test that analyzes 50 forms of circulating tumor DNA in the bloodstream; and ACT Risk, a screening of 67 cancer genes associated with 9 common hereditary cancers and 11 cancer syndromes. Prenetics Global Limited was founded in 2014 and is headquartered in Quarry Bay, Hong Kong.
Read More

Today's Range

Now: $5.15
Low: $4.99
High: $5.32

50 Day Range

MA: $4.97
Low: $4.16
High: $5.94

52 Week Range

Now: $5.15
Low: $3.84
High: $18.45

Volume

69,659 shs

Average Volume

20,669 shs

Market Capitalization

$47.07 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Prenetics Global?

The following Wall Street sell-side analysts have issued research reports on Prenetics Global in the last year: Cantor Fitzgerald.
View the latest analyst ratings for PRE.

What is the current price target for Prenetics Global?

1 Wall Street analysts have set twelve-month price targets for Prenetics Global in the last year. Their average twelve-month price target is $60.00, suggesting a possible upside of 1,065.0%. Cantor Fitzgerald has the highest price target set, predicting PRE will reach $60.00 in the next twelve months. Cantor Fitzgerald has the lowest price target set, forecasting a price of $60.00 for Prenetics Global in the next year.
View the latest price targets for PRE.

What is the current consensus analyst rating for Prenetics Global?

Prenetics Global currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PRE will outperform the market and that investors should add to their positions of Prenetics Global.
View the latest ratings for PRE.

What other companies compete with Prenetics Global?

How do I contact Prenetics Global's investor relations team?

Prenetics Global's physical mailing address is 71 Fort Street PO Box 500, Grand Cayman E9, KY1-1106. The company's listed phone number is 852-2210-9588. The official website for Prenetics Global is www.prenetics.com. Learn More about contacing Prenetics Global investor relations.